John Lim

Professor John CW Lim is founding Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS), inaugural Chairman of the Consortium for Clinical Research & Innovation Singapore (CRIS), Senior Advisor at Singapore’s Ministry of Health (MOH), and Policy Core Lead at the SingHealth Duke-NUS Global Health Institute (SDGHI). He is Professor of Practice at Duke-NUS and the NUS Saw Swee Hock School of Public Health.

Formerly Chief Executive Officer of Singapore’s Health Sciences Authority and Deputy Director of Medical Services (Industry & Research Matters) in MOH, Professor Lim has also held other senior positions in Singapore’s Health and Education ministries. His current roles promote capacity building and scientific excellence for health products regulation, health policies and systems in Southeast Asia and the Asia-Pacific.

Professor Lim is a member of the Singapore Food Agency Board, APEC Life Sciences Innovation Forum’s Executive Board, Davos Alzheimer’s Collaborative Leadership Group, US Pharmacopoeia (USP) Council of the Convention as Asia-Pacific Chapter Chair, USP Quality Institute’s Advisory Group, Centre for Innovation in Regulatory Science’s Scientific Advisory Council, and St Andrew’s Mission Hospital Board.

In 2018, Professor Lim received the Drug Information Association’s Global Connector Inspire Award for leadership in promoting global collaboration to advance healthcare products to patients, and the Regulatory Affairs Professional Society’s highest Founder’s Award recognising substantial sustained impact in shaping regulatory practice and policy over the course of his career.

Affiliation

• NUS Saw Swee Hock School of Public Health (Joint)
• Executive Director, Centre of Regulatory Excellence, Duke-NUS Graduate Medical School (Primary)
• Senior Advisor, Ministry of Health, Singapore
• Chairman, Singapore Clinical Research Institute

Research Areas

• Health Regulation/Regulatory Science

Teaching Areas

• Health Regulation/Regulatory Science
• Health Administration

Academic/Professional Qualifications

• MBBS (Singapore)
• M Sc (Public Health) (Singapore)
• SM (Health Policy & Management) (Harvard)
• AM (Singapore)

Awards

• Tye Cho Yook Gold Medal

Career History and Administrative Leadership

• Chief Executive Officer, Health Sciences Authority
• Administrator, Singapore Blood Transfusion Service
• Special Assistant to PS/DMS, Ministry of Health
• Deputy Director, Institute of Mental Health
• Deputy Director of Medical Services (Industry & Research Matters), Ministry of Health
• Director, Human Resource, Ministry of Health
• Director, Higher Education & Public Affairs, Ministry of Education
• Director, Centre for Drug Administration, Health Sciences Authority
• Deputy Chief Executive Officer, Health Sciences Authority

Selected Publications

• Lim JCW, Chan CL, Green A. Global Challenges in Regulatory Capacity and Capability Building: Extrapolating Lessons Learned From the HSA. Clinical Pharmacology & Therapeutics. 2018, Advance on line publication, November 20, 2018. DOI: 10.1002/cpt.1253
• Roth L, et al. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Globalization and Health, Open 2018, 14:102. DOI:10.1186/s12992-018-0421-2.
• Chong SSF, Lim JCW, Tominaga T. Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in Asia-Pacific Economic Co-operation (APEC). American Association of Pharmaceutical Scientists (AAPS) Open 2018, 4:4. DOI:10.1186/s41120-018-0024-2.
• Lim JCW. Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific. Therapeutic Innovation & Regulatory Science 2018, Vol. 52(6) 751-754. First published April 12, 2018. DOI: 10.1177/2168479018769285.
• Baird LG, et al. Accelerated access to innovative medicines for patients in need.Nature, Clinical Pharmacology & Therapeutics. 2014 Nov; 96(5):559-71. DOI: 10.1038/clpt.2014.145. First published July 9, 2014.
• Eichler HG, et al. Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval. Nature, Clinical Pharmacology & Therapeutics. 2012; 91(3):426–437. DOI: 10.1038/clpt.2011.345